AstraZeneca Share Price

AstraZeneca, China

AstraZeneca Talks Up US Growth as China Problems Fester

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid a probe that has battered the drugmaker’s share price.

The Financial Times · 1d

AstraZeneca chief says group takes China probe ‘very seriously’

AstraZeneca chief executive Pascal Soriot said the company took the detention of its China president “very seriously”, as the drugmaker raised its guidance for a second straight quarter on the back of strong sales of cancer medicines.

Reuters on MSN · 1d

AstraZeneca CEO says detained China chief has a lawyer but 'we have no information'

AstraZeneca's CEO said on Tuesday that the company's China president Leon Wang, who last month was detained by Chinese authorities, has a lawyer he is in touch with, but "we have no information as a company".

Barron's · 1d

Pharma Giant AstraZeneca Takes China Probes 'Very Seriously'

British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential illegal data collection and drug imports by the group that caused the detention of its China boss.

cnbctv183h

AstraZeneca India Q2 revenue surges 31% led by oncology, rare disease units

Profit after tax came in ₹38.4 crore in Q2 of FY25, a recovery from a net loss of ₹11.8 crore in the first quarter of this ...

Here's Why AstraZeneca (LON:AZN) Has Caught The Eye Of Investors

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...

Astrazeneca: FTSE 100 giant shrugs off China worries with profit upgrade

Astrazeneca has raised its guidance for the full year despite issues surrounding its presence in China according to today's ...

Hosted on MSN5d

What on earth is going on with the AstraZeneca share price?

The AstraZeneca (LSE:AZN) share price just dipped below £100 per share. The stock has seriously underperformed in recent months, falling from above £130 in August. So, let’s take a look at ...

BioSpace7d

AstraZeneca’s Stock Price Takes a Hit as China Chief Investigated for Insurance Fraud

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

Yahoo Finance7d

The AstraZeneca share price just fell 8.4% in a day. Is it time to consider buying?

The AstraZeneca (LSE: AZN) share price is in freefall at the moment. Yesterday (5 November), it fell 8.4%. Since late August, it has plummeted nearly 25%. So, what’s going on here? And has the ...

AstraZeneca Expected to Post Higher Core Earnings, Revenue -- Earnings Preview

CORE EARNINGS PER SHARE: One of the Anglo-Swedish pharmaceutical major's preferred metrics, core EPS is expected to come in at $2.04 in the third quarter, according to a company-compiled consensus ...

Investopedia on MSN7d

AstraZeneca Shares Slide As Execs in China Face Fraud Investigation

AstraZeneca.com. "AZN Share Price Movement." Bloomberg. “China Detains AstraZeneca Staff in Data, Drug-Import Probes.

Over £14bn wiped off AstraZeneca amid China fears

AstraZeneca suffered a £14bn share price hit on Tuesday after Chinese media reported more details about an investigation into ...

AstraZeneca: Contrarian Buy After The China Challenge (Rating Upgrade)

AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy AZN stock as big picture ...

1don MSN

AstraZeneca lifts guidance again as oncology drug sales soar to $5.6bn

The pharmaceutical giant expects overall sales and core earnings per share to rise by a high-teens percentage at constant ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

AstraZeneca, China

Related topics